Biotechnology Stocks I Performance Guide: MorphoSys AG (MOR)
MOR has no dividends
Table and Chart of MOR Performance
See what a $1,000 investment in MOR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MOR Returns | |
|---|---|
| Start Date | May-31-2018 |
| Start Price | $26.49 |
| End Date | Dec-01-2023 |
| End Price | $7.01 |
| # Prices | 68 |
| Min Date | Dec-30-2022 |
| Min Price | $3.58 |
| Max Date | Dec-31-2019 |
| Max Price | $35.67 |
| Total Return | -73.54% |
| Annualized Return | -20.91% |
| Current Value of $1,000 Purchase | $265 |
| Number Returns | 2,278 |
| Average Return | -38.79% |
| Number Profitable Returns | 475 |
| Percent Profitable Returns | 20.85% |
| Number Unprofitable Returns | 1,803 |
| Percent Unprofitable Returns | 79.15% |
| Profitable to Unprofitable Returns Ratio | 0.26 |
| MOR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $958,162,000 | Price to Sales | 3.67 |
| Earnings per Share | $0.7300 |
| PE Ratio | 9.6 |
| PE to Growth Ratio | None |
| Price to Book | 27.74 |
| PRICE DATA | |
| 52 Week High | $8.67 |
| 52 Week Low | $3.17 |
| Analyst Target Price | $10.16 |
| 50-Day Moving Average | $6.75 |
| 200-Day Moving Average | $6.43 |
| FINANCIAL DATA | |
| Revenue per Share | $1.909 |
| Revenue | $260,860,000 |
| Profit Margin | 35.1% |
| Return on Equity | 0.419% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MOR Compare Returns with S&P 500
MOR Trendline Chart